The economic impact of switching from Synthroid for the treatment of hypothyroidism

References

• Frank RG. The ongoing regulation of generic drugs. N Engl J Med 2007;357:1993-6
   PubMed Web of Science ®Google Scholar
• Generic Pharmaceutical Association. Generic drug savings in the U.S.: Seventh annual edition. GPA; 2015. Washington, DC. Available at: http://www.gphaonline.org/media/wysiwyg/PDF/GPhA_Savings_Report_2015.pdf
   Google Scholar
• Cameron A, Mantel-Teeuwisse AK, Leufkens HGM, et al. Switching from originator brand medicines to generic equivalents in selected developing countries: how much could be saved? Value Health J Int Soc Pharmacoecon Outcomes Res 2012;15:664-73
   Google Scholar
• Bennie M, Godman B, Bishop I, et al. Multiple initiatives continue to enhance the prescribing efficiency for the proton pump inhibitors and statins in Scotland. Expert Rev Pharmacoecon Outcomes Res 2012;12:125-30
   PubMed Web of Science ®Google Scholar
• Woerkom M van, Piepenbrink H, Godman B, et al. Ongoing measures to enhance the efficiency of prescribing of proton pump inhibitors and statins in The Netherlands: influence and future implications. J Comp Eff Res 2012;1:527-38
   PubMed Web of Science ®Google Scholar
• Wouters OJ, Kanavos PG, McKee M. Comparing generic drug markets in Europe and the United States: prices, volumes, and spending. Milbank Q 2017;95:554-601
   PubMed Web of Science ®Google Scholar
• Godman B, Shrank W, Andersen M, et al. Policies to enhance prescribing efficiency in Europe: findings and future implications. Front Pharmacol 2011;1:141
   PubMed Web of Science ®Google Scholar
• Hassali MA, Alrasheedy AA, McLachlan A, et al. The experiences of implementing generic medicine policy in eight countries: a review and recommendations for a successful promotion of generic medicine use. Saudi Pharm J SPJ 2014;22:491-503
   PubMed Web of Science ®Google Scholar
• Duerden MG, Hughes DA. Generic and therapeutic substitutions in the UK: are they a good thing? Br J Clin Pharmacol 2010;70:335-41
   PubMed Web of Science ®Google Scholar
• Yamada M, Welty TE. Generic substitution of antiepileptic drugs: a systematic review of prospective and retrospective studies. Ann Pharmacother 2011;45:1406-15
   PubMed Web of Science ®Google Scholar
• Cannon GW, DuVall SL, Haroldsen CL, et al. Clinical outcomes and biologic costs of switching between tumor necrosis factor inhibitors in US veterans with rheumatoid arthritis. Adv Ther 2016;33:1347-59
   PubMed Web of Science ®Google Scholar
• Johnston A, Stafylas P, Stergiou GS. Effectiveness, safety and cost of drug substitution in hypertension. Br J Clin Pharmacol 2010;70:320-34
   PubMed Web of Science ®Google Scholar
• Phillips B, Aziz F, O’Regan CP, et al. Switching statins: the impact of patient outcomes. Br J Cardiol 2007;14:280-5
   Google Scholar
• AACE, TES, and ATA joint position statement on the use and interchangeability of thyroxine products. 2004. Jacksonville, FL. Available at: https://www.aace.com/files/position-statements/aace-tes-ata-thyroxineproducts.pdf
   Google Scholar
• Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract 2012;18:988-1028.
   PubMed Web of Science ®Google Scholar
• Hansen LG, Chang S. Health research data for the real world: the MarketScan databases. 2011. Ann Arbor, MI: Truven Health Analytics. Available at: http://truvenhealth.com/portals/0/assets/PH_11238_0612_TEMP_MarketScan_WP_FINAL.pdf
   Google Scholar
• Truven Health MarketScan Research Databases. Commercial claims and Medicare supplemental: data year 2015 edition. 2016. Ann Arbor, MI: Truven Health Analytics. Available at: https://marketscan.truvenhealth.com/marketscanuniversity/userguide/2015%20MarketScanCCAE-MDCRUserGuide.pdf
   Google Scholar
• Bureau of Labor Statistics. Databases, tables & calculators by subject: inflation and prices. Washington, DC. Available at: http://www.bls.gov/data/#prices
   Google Scholar
• Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-19
   PubMed Web of Science ®Google Scholar
• Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005;43:1130-9
   PubMed Web of Science ®Google Scholar
• Tungol A, Starner CI, Gunderson BW, et al. Generic drug discount programs: are prescriptions being submitted for pharmacy benefit adjudication? J Manag Care Pharm 2012;18:690-700
   PubMed Web of Science ®Google Scholar
• Katz M, Scherger J, Conard S, et al. Healthcare costs associated with switching from brand to generic levothyroxine. Am Health Drug Benefits 2010;3:127-34
   PubMedGoogle Scholar
• Helmers SL, Paradis PE, Manjunath R, et al. Economic burden associated with the use of generic antiepileptic drugs in the United States. Epilepsy Behav 2010;18:437-44
   PubMed Web of Science ®Google Scholar
• Canaris GJ, Manowitz NR, Mayor G, et al. The Colorado thyroid disease prevalence study. Arch Intern Med 2000;160:526-34
   PubMed Web of Science ®Google Scholar
• Rodondi N, den Elzen WPJ, Bauer DC, et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA 2010;304:1365-74
   PubMed Web of Science ®Google Scholar
• Gencer B, Collet T-H, Virgini V, et al. Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from six prospective cohorts. Circulation 2012;126:1040-9
   PubMed Web of Science ®Google Scholar
• Vestergaard P. Skeletal effects of central nervous system active drugs: anxiolytics, sedatives, antidepressants, lithium and neuroleptics. Curr Drug Saf 2008;3:185-9
   PubMedGoogle Scholar
• Wartofsky L. Levothyroxine: therapeutic use and regulatory issues related to bioequivalence. Expert Opin Pharmacother 2002;3:727-32
   PubMedGoogle Scholar
• Shah RB, Collier JS, Sayeed VA, et al. Tablet splitting of a narrow therapeutic index drug: a case with levothyroxine sodium. AAPS PharmSciTech 2010;11:1359-67
   PubMed Web of Science ®Google Scholar
• Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement. Thyroid 2014;12:1670-751
   Google Scholar
• Colombo GL, Agabiti-Rosei E, Margonato A, et al. Impact of substitution among generic drugs on persistence and adherence: a retrospective claims data study from 2 local healthcare units in the Lombardy region of Italy. Atheroscler Suppl 2016;21:1-8
   PubMed Web of Science ®Google Scholar
• Håkonsen H, Eilertsen M, Borge H, et al. Generic substitution: additional challenge for adherence in hypertensive patients? Curr Med Res Opin 2009;25:2515-21
   PubMed Web of Science ®Google Scholar
• Desmarais JE, Beauclair L, Margolese HC. Switching from brand-name to generic psychotropic medications: a literature review. CNS Neurosci Ther 2011;17:750-60
   PubMed Web of Science ®Google Scholar
• Vanderpump M, Braverman L, Utiger R. Warner & Ingbar's The Thyroid: A Fundamental and Clinical Text In: Braverman, L and Utiger R., editors. The thyroid: A fundamental and clinical text. 9th ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2005. p 398-496
   Google Scholar